Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Todd Franklin Watanabe Insider Profile
4 Followers
Todd Franklin Watanabe, Reporting Person's title: President and CEO, Director at Arcutis Biotherapeutics, holds 1.06M shares in Arcutis Biotherapeutics (Ticker: ARQT). Most recently, Todd Franklin Watanabe Sold $13,871 shares of Arcutis Biotherapeutics on Nov 05, 2024 for an estimated value of 120.40K.
Todd Franklin Watanabe Arcutis Biotherapeutics (ARQT)Reporting Person's title: President and CEO, Director
Arcutis Biotherapeutics (ARQT)
Reporting Person's title: President and CEO, Director
Ranked #16,440 out of 99,335 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+175.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Todd Franklin Watanabe's holdings
Insider Roles
Reporting Person's title: President and CEO, Director
Roles that Todd Franklin Watanabe holds in companies
Most Profitable Insider Trade
The most profitable trade made by Todd Franklin Watanabe
Todd Franklin Watanabe's Trading History
List of latest transactions for each holding click on a transaction to see Todd Franklin Watanabe's performance on stock
You May Also Like
Todd Franklin Watanabe insider profile FAQ
What is the percentage of profitable transactions made by Todd Franklin Watanabe?
The percentage of profitable transactions made by Todd Franklin Watanabe is 50%.
What is the average return per transaction made by Todd Franklin Watanabe?
The average return per transaction made by Todd Franklin Watanabe is 175.50%.
What stocks does Todd Franklin Watanabe hold?
Todd Franklin Watanabe holds: ARQT stocks.
What was Todd Franklin Watanabe’s latest transaction?
Todd Franklin Watanabe latest transaction was an Informative Sell of $120.40K.
What was Todd Franklin Watanabe's most profitable transaction?
Todd Franklin Watanabe’s most profitable transaction was an Informative Buy of ARQT stock on December 1, 2023. The return on the trade was 367.30%.
What is Todd Franklin Watanabe's role in Arcutis Biotherapeutics?
Todd Franklin Watanabe's role in Arcutis Biotherapeutics is Reporting Person's title: President and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.